n-(3-(aminomethyl)benzyl)acetamidine has been researched along with sevoflurane in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Ma, LL; Qian, LB; Wang, WN; Yan, M; Yang, MJ; Yu, J; Yu, LN; Zhang, FJ | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and sevoflurane
| Article | Year |
|---|---|
Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.
Topics: Amidines; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; bcl-Associated Death Protein; Benzylamines; Blood Pressure; Decanoic Acids; Dietary Fats; Enzyme Inhibitors; Heart Ventricles; Hydroxy Acids; Hypercholesterolemia; Male; Methyl Ethers; Muscle Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Sevoflurane | 2012 |